Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related…

Overview of attention for article published in Journal of Psychopharmacology, February 2026

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users
facebook: 1 Facebook page

bluesky: 2 Bluesky users

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 2 Bluesky posts from 2 Bluesky users, with an upper bound of 2,004 followers.

A long but important read that imo covers most of the current issues with clinical trials involving psychedelics. journals.sagepub.com/doi/10.1177/...

Dr. Fred Barrett co-authored a new paper on the challenges of running rigorous psychedelic clinical trials — from expectancy effects to blinding. As therapies near FDA approval, strong science is essential. Read more: journals.sagepub.com/doi/10.1177/...

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.